We are live on
!
Find out more
SM
SB Management Portfolio holdings
AUM
$516M
1-Year Est. Return
40.71%
This Fund
S&P 500
This Quarter
Est. Return
-22.58%
1 Year Est. Return
-40.71%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$516M
AUM Growth
-$496M
(-49%)
Cap. Flow
-$237M
Cap. Flow
% of AUM
-45.9%
Top 10 Holdings %
Top 10 Hldgs %
99.28%
Holding
26
New
–
Increased
–
Reduced
3
Closed
6
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacific Biosciences
PACB
|
+$72.2M |
| 2 |
CPUH
Compute Health Acquisition Corp.
CPUH
|
+$38.9M |
| 3 |
Sana Biotechnology
SANA
|
+$34.2M |
| 4 |
REVH
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
|
+$29.2M |
| 5 |
Lyell Immunopharma
LYEL
|
+$27.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.01% |
| 2 | Consumer Discretionary | 7.75% |
| 3 | Financials | 7.07% |
| 4 | Industrials | 3.84% |
| 5 | Technology | 0% |
Similar funds
GH
HT
HAM
FC
FC
VR
MCM
TM
SB Management's Q1 2022 Portfolio in Review
As of Q1 2022, SB Management held 26 positions worth $516M, down 49% from $1.01B the previous quarter. Its ten largest holdings account for 99% of the portfolio.
SB Management withdrew a net $237M in Q1 2022, closing 6 positions and reducing 3 holdings. Its most notable exit was Compute Health Acquisition Corp., an estimated $38.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 70% a quarter earlier, followed by Consumer Discretionary and Financials.
- SB Management's biggest Q1 2022 reduction was Pacific Biosciences, cutting an estimated $72.2M.
- SB Management fully exited Compute Health Acquisition Corp. in Q1 2022, selling an estimated $38.9M.
- SB Management's ten largest holdings make up 99% of its $516M portfolio in Q1 2022.
- SB Management opened 0 new positions and closed 6 in Q1 2022.
- SB Management's portfolio value fell 49% quarter-over-quarter to $516M.
Based on SB Management's 13F filing for Q1 2022, filed 16 May 2022.